The Democratic Republic of the Congo’s ongoing Bundibugyo Ebola outbreak, now exceeding 7,000 cases and 3,400 deaths across seven provinces since its mid-May confirmation, dominates trader attention for 2026 markets. Recent spread to the remote northwestern South-Ubangi province via an infected traveler who crossed multiple borders has heightened concerns about export to neighboring Central African Republic and Republic of the Congo. Government data show declining incidence in the Ituri epicenter, yet weak surveillance, conflict-driven displacement, and school reopenings continue to fuel new transmission chains. Uganda’s smaller concurrent cluster ended in June with no further reports. Vaccination campaigns targeting frontline workers and expanded contact tracing represent key near-term catalysts, though the absence of a licensed Bundibugyo-specific vaccine limits containment speed. Traders monitor border movements and WHO assessments for signals of wider regional risk.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-updateWhich countries will have an Ebola case in 2026?
$38,659 Vol.
South Sudan
56%
Rwanda
22%
Burundi
48%
United States
20%
Canada
23%
Kenya
24%
India
46%
Republic of the Congo
25%
Nigeria
50%
Ethiopia
52%
Somalia
36%
China
14%
$38,659 Vol.
South Sudan
56%
Rwanda
22%
Burundi
48%
United States
20%
Canada
23%
Kenya
24%
India
46%
Republic of the Congo
25%
Nigeria
50%
Ethiopia
52%
Somalia
36%
China
14%
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Binuksan ang Market: May 22, 2026, 12:35 PM ET
Resolver
0x65070BE91...Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Resolver
0x65070BE91...The Democratic Republic of the Congo’s ongoing Bundibugyo Ebola outbreak, now exceeding 7,000 cases and 3,400 deaths across seven provinces since its mid-May confirmation, dominates trader attention for 2026 markets. Recent spread to the remote northwestern South-Ubangi province via an infected traveler who crossed multiple borders has heightened concerns about export to neighboring Central African Republic and Republic of the Congo. Government data show declining incidence in the Ituri epicenter, yet weak surveillance, conflict-driven displacement, and school reopenings continue to fuel new transmission chains. Uganda’s smaller concurrent cluster ended in June with no further reports. Vaccination campaigns targeting frontline workers and expanded contact tracing represent key near-term catalysts, though the absence of a licensed Bundibugyo-specific vaccine limits containment speed. Traders monitor border movements and WHO assessments for signals of wider regional risk.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-update


Mag-ingat sa mga external link.
Mag-ingat sa mga external link.
Mga Madalas na Tanong